Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;23(5):e13705.
doi: 10.1111/tid.13705. Epub 2021 Aug 3.

Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients

Saima Aslam  1 , Eric Adler  2 , Kristin Mekeel  3 , Susan J Little  1
Affiliations

Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients

Saima Aslam et al. Transpl Infect Dis. 2021 Oct.

Abstract

Goal: We aimed to assess the incidence rate of coronavirus disease 2019 (COVID-19) in vaccinated versus unvaccinated solid organ transplant recipients (SOTR) at our center.

Methods: We abstracted the following clinical data from our transplant registry from 1/1/2021 to 6/2/2021: demographics, details of COVID-19 vaccination, incidence of COVID-19, and related mortality. We calculated incidence of symptomatic COVID-19 per 1000/person days at risk and incidence rate ratio (IRR).

Results: Among 2151 SOTRs, 912 were fully vaccinated, and 1239 were controls (1151 unvaccinated, 88 partially vaccinated). Almost 70% of vaccinated subjects received the mRNA-1273 vaccine. There were 65 cases of COVID-19 that occurred during the study period - four occurred among fully vaccinated individuals and 61 among controls (including two in partially vaccinated individuals). Incidence rate for COVID-19 was 0.065 (95% CI 0.024-0.17) per 1000 person days in vaccinated versus 0.34 (95% CI 0.26-0.44) per 1000/person days in the control group; IRR was 0.19 (95% CI 0.049 -0.503, p < 0.005). There were no COVID-19 related deaths in the four breakthrough infections and two of 61 (3.3%) among controls.

Conclusion: We demonstrate real world clinical effectiveness of COVID-19 vaccination in SOTRs with an almost 80% reduction in the incidence of symptomatic COVID-19 versus unvaccinated SOTRs during the same time.

Keywords: COVID-19; SARS-CoV-2; Solid organ transplant; vaccine.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Kaplan–Meir curves demonstrating difference in cumulative probability of developing COVID‐19 in the control and vaccinated groups, along with 95% confidence intervals and p‐value of the associated log‐rank test
See this image and copyright information in PMC

References

    1. Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2‐Dose SARS‐CoV‐2 mRNA Vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204–2206. - PMC - PubMed
    1. Havlin J, Svorcova M, Dvorackova E, et al. Immunogenicity of BNT162b2 mRNA COVID19 vaccine and SARS‐CoV‐2 infection in lung transplant recipients. J Heart Lung Transplant. 2021;40:P754‐P758. - PMC - PubMed
    1. Malinis M, Cohen E, Azar MM. Effectiveness of SARS‐CoV‐2 vaccination in fully vaccinated solid organ transplant recipients. Am J Transplant. 2021. 10.1111/ajt.16713. - DOI - PMC - PubMed
    1. Kamar N, Abravanel F, Marion O, Couat C, Izopet J, Del Bello A. Three doses of an mRNA covid‐19 vaccine in solid‐organ transplant recipients. N Engl J Med. 2021. 10.1056/NEJMc2108861. - DOI - PMC - PubMed
    1. Burack D, Pereira MR, Tsapepas DS, et al. Prevalence and predictors of SARS‐CoV‐2 antibodies among solid organ transplant recipients with confirmed infection. Am J Transplant. 2021;21(6):2254–2261. - PMC - PubMed

Substances